On Monday, Agilon Health Inc (NYSE: AGL) opened lower -5.70% from the last session, before settling in for the closing price of $2.98. Price fluctuations for AGL have ranged from $2.98 to $19.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 53.71%. Company’s average yearly earnings per share was noted 25.75% at the time writing. With a float of $302.82 million, this company’s outstanding shares have now reached $406.39 million.
Let’s determine the extent of company efficiency that accounts for 1117 employees. In terms of profitability, gross margin is 0.49%, operating margin of -4.86%, and the pretax margin is -4.19%.
Agilon Health Inc (AGL) Insider Activity
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of Agilon Health Inc is 26.41%, while institutional ownership is 86.92%. The most recent insider transaction that took place on Sep 12 ’24, was worth 67,188. In this transaction CEO & President of this company bought 20,000 shares at a rate of $3.36, taking the stock ownership to the 67,590 shares. Before that another transaction happened on Nov 29 ’23, when Company’s Director bought 22,300 for $11.22, making the entire transaction worth $250,206. This insider now owns 31,931 shares in total.
Agilon Health Inc (AGL) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.08 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.06) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.75% per share during the next fiscal year.
Agilon Health Inc (NYSE: AGL) Trading Performance Indicators
Check out the current performance indicators for Agilon Health Inc (AGL). In the past quarter, the stock posted a quick ratio of 1.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.62, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.15 in one year’s time.
Technical Analysis of Agilon Health Inc (AGL)
Looking closely at Agilon Health Inc (NYSE: AGL), its last 5-days average volume was 5.5 million, which is a jump from its year-to-date volume of 4.98 million. As of the previous 9 days, the stock’s Stochastic %D was 33.01%. Additionally, its Average True Range was 0.31.
During the past 100 days, Agilon Health Inc’s (AGL) raw stochastic average was set at 0.81%, which indicates a significant decrease from 4.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.69% in the past 14 days, which was higher than the 78.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.84, while its 200-day Moving Average is $5.54. However, in the short run, Agilon Health Inc’s stock first resistance to watch stands at $2.95. Second resistance stands at $3.09. The third major resistance level sits at $3.18. If the price goes on to break the first support level at $2.72, it is likely to go to the next support level at $2.63. Should the price break the second support level, the third support level stands at $2.49.
Agilon Health Inc (NYSE: AGL) Key Stats
There are currently 411,262K shares outstanding in the company with a market cap of 1.16 billion. Presently, the company’s annual sales total 4,316 M according to its annual income of -262,600 K. Last quarter, the company’s sales amounted to 1,483 M and its income totaled -30,680 K.
